Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report

Immune checkpoint inhibitors became the treatment of choice, in monotherapy or in association with platinum-based doublet chemotherapy, in first-line therapy for advanced-stage non-small-cell lung cancer without oncogenic driver. Nevertheless, it can be associated with diverse immune-related adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Quirynen, Rémy, Ocak, Sebahat, Duplaquet, Fabrice, Pirard, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413185/
https://www.ncbi.nlm.nih.gov/pubmed/37577125
http://dx.doi.org/10.1016/j.rmcr.2023.101898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413185/
https://www.ncbi.nlm.nih.gov/pubmed/37577125
http://dx.doi.org/10.1016/j.rmcr.2023.101898

Ejemplares similares